Earnings call transcript: Calian Group Q2 2026 shows strong growth, stock dips

Calian reported record Q2 2026 revenue of CAD 229 million, up 18% year over year, with gross profit up 24% to CAD 80 million and adjusted EBITDA up 60% to CAD 28 million. Gross margin improved to 35.1% from 33.4%, and the company lifted its FY2026 outlook to low-teens revenue growth and high-teens adjusted EBITDA growth. Shares still fell 0.95% to CAD 68 as operating cash flow dropped to CAD 1 million from CAD 10 million, tempering the otherwise strong operating results.

Analysis

The market is treating this like a quality-versus-cash-flow mismatch, but the more important read-through is that Calian is transitioning from a mostly project-led services name into a backlog-backed defense compounder. With defense contract awards building and Europe increasingly becoming a second growth vector, the earnings power is likely to re-rate ahead of reported revenue, not after it — especially if management keeps converting awards into multi-year programs. That said, the stock may stay capped in the near term until investors see receivables normalize; the optics of weak operating cash flow can matter more than adjusted EBITDA for another 1-2 quarters.

The second-order implication is that Calian’s margin expansion is not purely cyclical; it is increasingly mix-driven toward higher-value product and technology content. That benefits suppliers and integration partners tied to defense electronics, space systems, and cyber, while pressuring smaller pure-services competitors that lack cross-selling breadth or contract scale. The flip side is that larger contract wins can create working-capital drag before cash conversion catches up, so the next catalyst is not just another contract announcement but evidence that cash conversion follows backlog growth.

Consensus is likely underestimating how much of the defense thesis is now self-reinforcing: procurement acceleration, backlog visibility, and acquisition capacity are all feeding each other. The market is also probably over-penalizing the cash flow dip as if it were structural, when part of it is a timing effect tied to scaling receivables; if that unwinds over the next 1-2 quarters, the stock can recover quickly. The real risk is not cash flow per se, but a slower-than-expected conversion of defense awards into billable work, or margin dilution if Europe ramp and M&A absorb capital before synergies show up.

Key Decisions for Investors

• Long CGY.TO on a 3-6 month horizon: use the post-earnings pullback as entry, targeting a re-rating if working capital normalizes and backlog conversion is visible; upside is backlog-to-EBITDA multiple expansion, downside is another quarter of cash flow disappointment.
• Pair trade: long CGY.TO / short a lower-quality Canadian defense-services or IT-services peer with weaker backlog visibility over the next 1-2 quarters; thesis is that CGY’s defense momentum and acquisition optionality should outperform as contracts convert.
• Buy CGY.TO call spreads 3-6 months out if available liquidity stays strong and management delivers on receivables conversion; structure for 2:1 to 3:1 payoff if the market starts valuing defense backlog more than near-term cash flow.
• Avoid chasing immediately after further contract headlines unless accompanied by cash conversion data; this is a 'show-me-the-cash' name for the next two reporting cycles, not just a backlog story.
• Monitor AMS-related cross-sell and European investment spend as a catalyst pair: if those show operating leverage within 2 quarters, add to longs; if not, trim given the risk that M&A and expansion temporarily suppress FCF.